Navigation Links
Mindray Announces 2008 Fourth Quarter and Full Year Results
Date:3/4/2009

SHENZHEN, China, March 4 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2008. The financial results reported below include the results of operations of the patient monitoring business acquired from Datascope ("DPM") starting from May 1, 2008.

    Highlights for Fourth Quarter and Full Year 2008

    -- Full year 2008 revenue generated in China and international markets
       increased 61.1% and 110.4%, respectively, over 2007 to a total of
       $547.5 million
    -- Full year 2008 non-GAAP net income, as defined below, increased 49.7%
       year-over-year to $132.7 million
    -- Full year 2008 non-GAAP diluted EPS, as defined below, increased 48.8%
       year-over-year to $1.17
    -- Strong fourth quarter operating cash flow of $40.0 million
    -- Company further improved product mix and achieved new product
       development goals for 2008 with ten products brought to market across
       all 3 product segments
    -- Enhanced presence in U.S. market and received FDA 510(k) clearance for
       nine products
    -- Company declares 2008 dividend of $0.20 per share

"Mindray has continued to deliver strong results despite a challenging economic environment in the fourth quarter 2008," commented Mr. Xu Hang, Mindray's chairman and co-chief executive officer. "In 2008, we successfully completed and delivered initial synergy targets from the acquisition of Datascope's patient monitoring business which greatly expanded our geographic footprint in North America and strengthened our presence in Europe. Fully leveraging the strength of our internal R&D and sales and marketing ca
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Mindray Medical International Announces Second Quarter 2008 Results
2. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
3. Mindray Medical International Announces First Quarter 2008 Results
4. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
5. Mindray Medical International Announces Third Quarter 2007 Results
6. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
7. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
8. Martek Announces First Quarter 2009 Financial Results
9. Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors
10. STAAR Surgical Announces Fourth Quarter and Full Year 2008 Earnings Release Date and Conference Call
11. Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... April 23, 2015 Follow ... to a series of genetic tests that determine ... Lou Gehrig's disease, Huntington's disease, and Alzheimer's disease. ... gene composition and interaction in diseased tissue/cells to ... well as the response to treatment, such as ...
(Date:4/23/2015)... (PRWEB) April 23, 2015 ... is the first EMC® Enterprise Content Division (ECD) ... entire EMC Documentum® for Life Sciences Solution ... proven knowledge and capabilities to provide life sciences ... solutions. , The EMC Documentum Solution Suite ...
(Date:4/23/2015)... , April 23, 2015 /PRNewswire/ - Crystal Research ... Executive Informational Overview ® (EIO) on Aeterna Zentaris ... report is available on Crystal Research Associates, website at ... Aeterna Zentaris, website at www.aezsinc.com . ... a specialty biopharmaceutical company in oncology, endocrinology, and women,s ...
(Date:4/22/2015)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ) today ... For the first quarter ended March 31, ... million, or $0.08 per share, compared to a net ... the same period in 2014. As of March 31, ... and interest receivable of $226.1 million. Revenues ...
Breaking Biology Technology:Increasing Disease Prevalence & Focus on Preventive Healthcare Drive the Predictive Diagnostics Market, According to a New Report by Global Industry Analysts, Inc. 2Increasing Disease Prevalence & Focus on Preventive Healthcare Drive the Predictive Diagnostics Market, According to a New Report by Global Industry Analysts, Inc. 3Glemser Earns Accreditation for Life Sciences Solution Suite 2Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc. 2Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc. 3Sangamo BioSciences Reports First Quarter 2015 Financial Results 2Sangamo BioSciences Reports First Quarter 2015 Financial Results 3Sangamo BioSciences Reports First Quarter 2015 Financial Results 4Sangamo BioSciences Reports First Quarter 2015 Financial Results 5Sangamo BioSciences Reports First Quarter 2015 Financial Results 6Sangamo BioSciences Reports First Quarter 2015 Financial Results 7Sangamo BioSciences Reports First Quarter 2015 Financial Results 8
... , CLEVELAND , June 28 ... Association as a Venture of Year Award Finalist. Founded ... engineering based therapies, Arteriocyte focuses on developing commercially available ... derived stem cells (marrow, peripheral cord blood, and cartilage) ...
... ... tool for the analysis of metabolites in plants , ... Amsterdam, The Netherlands (PRWEB) June 28, 2010 -- Genedata, a leading ... new Refiner MS at the 6th Metabolomics Conference 2010. Part of Genedata Expressionist ...
... ... 2009, to $295M worldwide; and is forecasted to reach $4B in 2015. , ... San Francisco, CA (PRWEB) June 28, 2010 ... and treat cognition, or digital brain health and fitness tools, grew 35% in ...
Cached Biology Technology:Arteriocyte Named Top Biotech Start Up Venture by the Ohio Venture Association for 2010 2Arteriocyte Named Top Biotech Start Up Venture by the Ohio Venture Association for 2010 3Genedata's Refiner MS Used by Max Planck Institute will Demo at Metabolomics Conference 2010 2Genedata's Refiner MS Used by Max Planck Institute will Demo at Metabolomics Conference 2010 3Genedata's Refiner MS Used by Max Planck Institute will Demo at Metabolomics Conference 2010 4New Report Finds A Brain Health Revolution in the Making, Driven by Digital Technology and Neuroplasticity Research 2New Report Finds A Brain Health Revolution in the Making, Driven by Digital Technology and Neuroplasticity Research 3New Report Finds A Brain Health Revolution in the Making, Driven by Digital Technology and Neuroplasticity Research 4New Report Finds A Brain Health Revolution in the Making, Driven by Digital Technology and Neuroplasticity Research 5
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and ... addition of the "Global Iris Recognition Market 2015-2019" ... forecast the Global Iris Recognition market to grow at ... This report covers the present scenario and ... for the period 2015-2019. To calculate the market size, ...
(Date:3/23/2015)... 23, 2015   HOYOS Labs , a leading ... announced that the Company will demonstrate multiple biometrics-based technologies ... consumers at Connect:ID on March 23 through 25, 2015, ... will highlight the IEEE Biometric Open Protocol Standard; free ... enterprise access control system. BOPS was invented by HOYOS ...
(Date:3/20/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces its ... of the products featured in 2015 "I Want That" ... PM EST on the DIY Network.   ... Vegas , site of the 2015 International CES ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... May 22, 2011 -- The stomach bacteria responsible ... development of Parkinson,s disease according to research presented today ... for Microbiology. "Infection of late middle-aged mice with ... results in development of Parkinson,s disease symptoms after ...
... Texas No one knows the cause of most ... researchers have found that certain factors are consistently associated ... reactive oxygen species, highly destructive molecules usually formed as ... of excessive levels of copper and iron in regions ...
... New research at UC Santa Barbara is contributing to ... is part of the campus,s expanding vision research. The ... Proceedings of the National Academy of Sciences (PNAS), ... The scientists document how they used mice as a research ...
Cached Biology News:Ulcer bacteria may contribute to development of Parkinson's disease 2High iron, copper levels block brain-cell DNA repair 2UCSB scientists make strides in vision research 2
... The FP-6500 is the research-grade spectrofluorometer ... a highest sensitivity S/N ratio 200 or ... ,The FP-6500 is especially designed to keep ... in biochemistry as kinetics, stopped-flow, titration, or ...
... microRNA expression profiling and built on ... on-chip synthesis platform. These microarrays are ... microRNA Expression Profiling Service. ... Microarray contains all known arabidopsis microRNAs ...
... Microarrays designed for genome-wide microRNA expression profiling ... Paraflo microfluidic on-chip synthesis platform. These microarrays ... microRNA Expression Profiling Service. Probe ... all known cow microRNAs (108 unique mature ...
... genome-wide microRNA expression profiling and built ... microfluidic on-chip synthesis platform. These microarrays ... comprehensive microRNA Expression Profiling Service. ... microRNA Microarray contains all known virus ...
Biology Products: